| m6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells QI Cui, H Shi, P Ye, L Li, Q Qu, G Sun, G Sun, Z Lu, Y Huang, CG Yang, ... Cell reports 18 (11), 2622-2634, 2017 | 1210 | 2017 |
| Adaptive amphiphilic dendrimer‐based nanoassemblies as robust and versatile siRNA delivery systems X Liu, J Zhou, T Yu, C Chen, Q Cheng, K Sengupta, Y Huang, H Li, C Liu, ... Angewandte Chemie International Edition 53 (44), 11822-11827, 2014 | 222 | 2014 |
| ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response C Wang, M Zhang, G Garcia, E Tian, Q Cui, X Chen, G Sun, J Wang, ... Cell stem cell 28 (2), 331-342. e5, 2021 | 203 | 2021 |
| GFAP mutations in astrocytes impair oligodendrocyte progenitor proliferation and myelination in an hiPSC model of Alexander disease L Li, E Tian, X Chen, J Chao, J Klein, Q Qu, G Sun, G Sun, Y Huang, ... Cell stem cell 23 (2), 239-251. e6, 2018 | 124 | 2018 |
| The TLX-miR-219 cascade regulates neural stem cell proliferation in neurodevelopment and schizophrenia iPSC model K Murai, G Sun, P Ye, E Tian, S Yang, Q Cui, G Sun, D Trinh, O Sun, ... Nature communications 7 (1), 10965, 2016 | 118 | 2016 |
| Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis Q Cui, K Yin, X Zhang, P Ye, X Chen, J Chao, H Meng, J Wei, D Roeth, ... Nature cancer 2 (9), 932-949, 2021 | 107 | 2021 |
| Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis Q Cui, S Yang, P Ye, E Tian, G Sun, J Zhou, G Sun, X Liu, C Chen, ... Nature communications 7 (1), 10637, 2016 | 89 | 2016 |
| Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants NM Snead, X Wu, A Li, Q Cui, K Sakurai, JC Burnett, JJ Rossi Nucleic acids research 41 (12), 6209-6221, 2013 | 82 | 2013 |
| Decoding pseudouridine: an emerging target for therapeutic development J Cerneckis, Q Cui, C He, C Yi, Y Shi Trends in pharmacological sciences 43 (6), 522-535, 2022 | 80 | 2022 |
| The anticancer activity of a first-in-class small-molecule targeting PCNA L Gu, R Lingeman, F Yakushijin, E Sun, Q Cui, J Chao, W Hu, H Li, ... Clinical Cancer Research 24 (23), 6053-6065, 2018 | 44 | 2018 |
| Comparative transcriptomic analysis of SARS-CoV-2 infected cell model systems reveals differential innate immune responses G Sun, Q Cui, G Garcia Jr, C Wang, M Zhang, V Arumugaswami, ... Scientific Reports 11 (1), 17146, 2021 | 33 | 2021 |
| N6-methyladenosine promotes induction of ADAR1-mediated A-to-I RNA editing to suppress aberrant antiviral innate immune responses H Terajima, M Lu, L Zhang, Q Cui, Y Shi, J Li, C He PLoS biology 19 (7), e3001292, 2021 | 31 | 2021 |
| Cell‐based therapy for canavan disease using human iPSC‐derived NPCs and OPCs L Feng, J Chao, E Tian, L Li, P Ye, M Zhang, X Chen, Q Cui, G Sun, ... Advanced Science 7 (23), 2002155, 2020 | 27 | 2020 |
| Nuclear receptor TLX in development and diseases G Sun, Q Cui, Y Shi Current Topics in Developmental Biology 125, 257-273, 2017 | 24 | 2017 |
| Developing hypoimmunogenic human iPSC‐derived oligodendrocyte progenitor cells as an off‐the‐shelf cell therapy for myelin disorders L Feng, J Chao, P Ye, Q Luong, G Sun, W Liu, Q Cui, S Flores, N Jackson, ... Advanced Science 10 (23), 2206910, 2023 | 13 | 2023 |
| Therapeutic development for Canavan disease using patient iPSCs introduced with the wild-type ASPA gene J Chao, L Feng, P Ye, X Chen, Q Cui, G Sun, T Zhou, E Tian, W Li, W Hu, ... IScience 25 (6), 2022 | 9 | 2022 |
| Viral and Host Small RNA Response to SARS-CoV-2 Infection G Sun, Q Cui, G Garcia Jr, EM Lizhar, V Arumugaswami, Y Shi, AD Riggs Microbiology Research 13 (4), 788-808, 2022 | 5 | 2022 |
| Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection Q Cui, G Garcia, M Zhang, C Wang, H Li, T Zhou, G Sun, ... Iscience 25 (1), 2022 | 5 | 2022 |
| The Apolipoprotein E neutralizing antibody inhibits SARS‐CoV‐2 infection by blocking cellular entry of lipoviral particles Q Cui, AV Jeyachandran, G Garcia jr, C Qin, Y Zhou, M Zhang, C Wang, ... MedComm 4 (5), e400, 2023 | 4 | 2023 |
| Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells Y Qin, Q Cui, G Sun, J Chao, C Wang, X Chen, P Ye, T Zhou, ... Cell Reports 43 (11), 2024 | 2 | 2024 |
yanhong shiZweryfikowany adres z coh.org
